Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA A receptors (GABA A R). BDZs and other positive GABA A R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability. Because neuronal L-VGCC function is up-regulated after long-term GABA A R modulator exposure, an interaction with L-VGCCs may also play a role in physical dependence. The current studies assessed the effects of BDZs (diazepam, flurazepam, and desalkylflurazepam), allopregnanolone, pentobarbital, and ethanol on whole-cell Ba 2ϩ currents through recombinant neuronal Ca v 1.2 and Ca v 1.3 L-VGCCs expressed with  3 and ␣ 2 ␦-1 in HEK293T cells. Allopregnanolone was the most potent inhibitor (IC 50 , ϳ10 M), followed by BDZs (IC 50 , ϳ50 M), pentobarbital (IC 50 , 0.3-1 mM), and ethanol (IC 50 , ϳ300 mM). Ca v 1.3 channels were less sensitive to pentobarbital inhibition than Ca v 1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists. All GABA A R modulators induced a negative shift in the steady-state inactivation curve of Ca v 1.3 channels, but only BDZs and pentobarbital induced a negative shift in Ca v 1.2 channel inactivation. Mutation of the high-affinity DHP binding site (T1039Y and Q1043M) in Ca v 1.2 channels reduced pentobarbital potency. Despite the structural similarity between benzothiazepines and BDZs, mutation of an amino acid important for diltiazem potency (I1150A) did not affect diazepam potency. Although L-VGCC inhibition by BDZs occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the up-regulation of L-VGCCs during long-term treatment, pentobarbital and ethanol inhibited L-VGCCs at clinically relevant concentrations.